- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Kabra Drugs Ltd Pharmaceuticals - Indian - Formulations
- Indian Private
- BSE Code : 2908.0
- ISIN : INE323K01017
-
Today’s Low
11.08 -
Today’s High
11.08

-
Open
11.08 -
Perv Close
10.56 -
52W Low
7.19 -
52W High
11.08
Key Indicators
-
P/E(TTM)
0.00
-
Mar.Cap (₹Cr.)
26.27
-
Div & Yield %
0.00
-
Book Value(₹)
10.58
-
Debt-Equity Ratio
4.92
-
AGM Date
17-Mar-2025
-
EPS
0.00
-
P/E Ratio
0.00
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
26.27
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
23.71
-
BV (₹)
10.60
-
Sales( ₹ in Cr.)
0.00
-
NP (in Cr.)
-0.74
-
NP Var(%)
-118.0
-
Div%
0.0
-
CPS (₹)
-0.30
-
EPS (₹)
-0.30
-
Traded Value (₹ in Lakhs)
26.27
-
52 Week High
11.08
-
52 Week Low
7.19
-
Price BSE
11.0
-
Price NSE
0.00
-
Market Capital( in Cr.)
26.27
-
P/C Ratio
-35.40
-
P/E Ratio
-35.40
-
Price Vs.BV
-0.30
-
15-Feb-2025( 07:41)
Results - Announcements - Kabra... - Net Loss of Kabra Drugs report...
-
08-Feb-2025( 11:03)
Corporate News - Kabra... - Kabra Drugs will hold a meetin...
-
05-Dec-2024( 05:27)
Corporate News - Kabra... - Kabra Drugs announced that an...
-
26-Nov-2024( 09:56)
Corporate News - Kabra... - Kabra Drugs will hold a meetin...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
---|---|---|---|---|---|---|
Sales Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 0.00 | 0.01 | 0.00 | 0.00 | 0.02 | 0.01 |
Stock Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Income | 0.00 | 0.01 | 0.00 | 0.00 | 0.02 | 0.01 |
EXPENDITURE : | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Power & Fuel Cost | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Employee Cost | 0.40 | 0.23 | 0.09 | 0.05 | 0.00 | 0.03 |
Other Manufacturing Expenses | 0.04 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
Selling & Administrative Expenses | 0.30 | 0.09 | 0.08 | 0.10 | 0.05 | 0.10 |
Miscellaneous Expenses | 0.04 | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 |
Less : Pre-operative Expenses Capitalised : | ||||||
Total Expenditure | 0.74 | 0.34 | 0.19 | 0.18 | 0.08 | 0.17 |
Operating Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Gross Profit | -0.74 | -0.34 | -0.19 | -0.18 | -0.06 | -0.16 |
Depreciation | 0.00 | 0.00 | 0.01 | 0.03 | 0.03 | 0.03 |
Profit Before Tax | -0.74 | -0.34 | -0.19 | -0.18 | -0.06 | -0.16 |
Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Reported Net Profit | -0.74 | -0.34 | -0.19 | -0.18 | -0.06 | -0.16 |
Extraordinary Items | -0.74 | -0.34 | -0.19 | -0.18 | -0.06 | -0.16 |
Adjusted Net Profit | -0.74 | -0.34 | -0.19 | -0.18 | -0.06 | -0.16 |
Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance brought forward | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance carried down | -0.74 | -0.34 | -0.19 | -0.18 | -0.06 | -0.16 |
Dividend | - | - | - | - | - | - |
Preference Dividend | - | - | - | - | - | - |
Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Per Share-Unit Curr | -1.68 | -0.77 | -0.42 | -0.41 | -0.14 | -0.38 |
Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book Value(Adj)-Unit Curr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Background
Kabra Drugs LtdPharmaceuticals - Indian - Formulations
- Kabra Drugs Ltd
- BSE Code : 2908.0
- ISIN : INE323K01017
-
Incorporation Year
1989
-
Registered Office
270 Shastri Market Indore
, Indore,
Madhya Pradesh-452007 -
Telephone
-
FAX
-
Chairman
-
Managing Director
N Aravind
-
Company Secretary
Monika Sanwal
-
Auditor
Rishi Sekhri & Associates/PPN and Company
-
Face Value
10
-
Listing
BSE
-
Registrar
Ankit Consultancy Pvt Ltd
Plot No. 60,
Electronic Complex,Pardeshipura
Mumbai - Indore - 452010
Kabra Drugs Ltd Peer Comparison
Select | Company Name | LTP (₹) | Revenue | Sales | P/E Ratio | ROCE % |
---|---|---|---|---|---|---|
Kabra Drugs | 11.08 | 0.00 | 0.00 | -14.21 | 0.00 | |
Abbott India | 30,730.65 | 6,097.18 | 5,848.91 | 48.94 | 44.71 | |
Astrazeneca Phar | 8,606.35 | 1,330.33 | 1,295.53 | 221.87 | 33.26 | |
P & G Health Ltd | 5,142.30 | 1,166.89 | 1,151.26 | 36.08 | 39.76 | |
Glaxosmi. Pharma | 2,877.30 | 3,530.73 | 3,407.25 | 57.21 | 44.44 | |
Cipla | 1,441.70 | 17,645.00 | 16,574.34 | 24.72 | 20.10 | |
Amrutanjan Healt | 644.85 | 437.58 | 421.23 | 37.80 | 20.84 | |
Guj. Themis Bio. | 281.50 | 174.19 | 169.82 | 58.28 | 44.82 | |
Fermenta Biotec. | 273.55 | 315.24 | 307.09 | 25.93 | 4.10 | |
Bliss GVS Pharma | 117.55 | 638.96 | 605.46 | 26.90 | 11.19 | |
Ambalal Sarabhai | 35.05 | 11.70 | 3.81 | 14.98 | 1.92 |